[EN] HETEROCYCLIC-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS [FR] COMPOSÉS PYRIDYLE À SUBSTITUTION HÉTÉROCYCLIQUE UTILES EN TANT QU'INHIBITEURS DE KINASES
[EN] THIAZOLYL- OR THIADIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS [FR] COMPOSÉS PYRIDYLES SUBSTITUÉS PAR THIAZOLYL OU THIADIAZOLYL UTILES EN TANT QU'INHIBITEURS DE KINASE
[EN] THIAZOLYL- OR THIADIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS<br/>[FR] COMPOSÉS PYRIDYLES SUBSTITUÉS PAR THIAZOLYL OU THIADIAZOLYL UTILES EN TANT QU'INHIBITEURS DE KINASE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2013106641A1
公开(公告)日:2013-07-18
Compounds having the following formula (I) or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein X is N or C-R7, are useful as kinase modulators, including IRAK-4 modulation.
HETEROCYCLIC-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS
申请人:Bristol-Myers Squibb Company
公开号:US20150011532A1
公开(公告)日:2015-01-08
Compounds having the following formula: wherein A is, or; and X is N or C—R
7
, or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, are useful as kinase modulators, including IRAK-4 modulation.
THIAZOLYL- OR THIADIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20150018344A1
公开(公告)日:2015-01-15
Compounds having the following formula (I) or an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein X is N or C—R
7
, are useful as kinase modulators, including IRAK-4 modulation.
Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
申请人:Bristol-Myers Squibb Company
公开号:US08987311B2
公开(公告)日:2015-03-24
Compounds having the following formula: (I) wherein: A is an optionally substituted triazole, or a stereoisomer or a pharmaceutically-acceptable salt thereof, are useful as kinase modulators, including IRAK-4 modulation.
TRIAZOLYL-SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE INHIBITORS
申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20150045347A1
公开(公告)日:2015-02-12
Compounds having the following formula: (I) wherein: A is an optionally substituted triazole, or a stereoisomer or a pharmaceutically-acceptable salt thereof, are useful as kinase modulators, including IRAK-4 modulation.